Head-to-head
NexLife vs Henry Meds
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. NexLife is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NexLife is $139 a month all-in for semaglutide; Henry Meds is $297. Over twelve months that is $1,428 against $3,564. Value Scores are 89.0 and 60.4 out of 100.
Semaglutide
Plan pages: NexLife plans · Henry Meds plans
At 2.4 mg/week, NexLife is $139 a month all-in and Henry Meds is $297 — $158 apart, or $1,896 across a year. Over twelve months the totals are $1,428 (prepaid term) and $3,564 (billed monthly).
NexLife charges a flat $139 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Henry Meds charges a flat $297 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | NexLife | Rank | Henry Meds | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $139 | 5/32 | $297 | 25/32 | NexLife by $158 |
| 0.5 mg | $139 | 4/21 | $297 | 16/21 | NexLife by $158 |
| 1 mg | $139 | 4/21 | $297 | 16/21 | NexLife by $158 |
| 1.7 mg | $139 | 4/21 | $297 | 16/21 | NexLife by $158 |
| 2.4 mg | $139 | 4/29 | $297 | 22/29 | NexLife by $158 |
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, NexLife sits 4 of 29 on all-in monthly cost and Henry Meds sits 20. There are 15 other programs priced between them. The field median is $249 and the floor is $129, so NexLife is below the median and the other is above it. NexLife is $10 above the cheapest semaglutide program on record. Henry Meds is $168 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — NexLife undercuts it by $210, Henry Meds by $52. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NexLife | Henry Meds | Cheaper |
|---|---|---|---|
| Month to month | $139 | $297 | NexLife by $158 |
| 3-month term | $132 | — | only NexLife publishes this term |
| 6-month term | $125 | — | only NexLife publishes this term |
| 12-month term | $119 | — | only NexLife publishes this term |
| Settled dose | NexLife | Henry Meds | Difference |
|---|---|---|---|
| 0.25 mg | $1,668 | $3,564 | $1,896 apart |
| 0.5 mg | $1,668 | $3,564 | $1,896 apart |
| 1 mg | $1,668 | $3,564 | $1,896 apart |
| 1.7 mg | $1,668 | $3,564 | $1,896 apart |
| 2.4 mg | $1,668 | $3,564 | $1,896 apart |
Henry Meds publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,668 on NexLife and $3,564 on Henry Meds. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 89.0 for NexLife and 60.4 for Henry Meds, against a semaglutide category floor of $129. NexLife leads by 28.6 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NexLife | 65.0 | 9.0 | 10 | 5 | 89.0 |
| Henry Meds | 30.4 | 15.0 | 10 | 5 | 60.4 |
Where the two programs differ
All-in monthly
NexLife is cheaper month to month — $139 against $297, a gap of $158 every month, or $1,896 across a year if both rates hold.
Cancellation terms
Cancellation differs: NexLife states Cancel anytime with 30 days' notice (per published terms), while Henry Meds states Cancel before renewal; bundle refunds limited. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NexLife asks for None on monthly; 3/6/12-month plans are prepaid terms; Henry Meds asks for Month-to-month; 6/12-month bundles prepaid. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. NexLife's figure is operator-stated and Henry Meds's is verified. Henry Meds rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,428 for NexLife and $3,564 for Henry Meds. NexLife is lower by $2,136 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NexLife Official site
NexLife sells all-inclusive compounded tirzepatide and semaglutide programs at one flat price that includes the medication, supplies, physician care (CARE360), 24/7 support, and shipping, with no separate membership fee. Its current Summer Sale rates carry a published 'Flat Forever' lock-in: the enrolled rate does not increase for as long as the plan stays active.
It names its compounding pharmacy — Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability), recorded as Named 503A/503B network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on monthly; 3/6/12-month plans are prepaid terms; cancellation is Cancel anytime with 30 days' notice (per published terms); availability is stated as Most US states; confirmed at intake.
Evidence: operator-stated — supplied by the operator with screenshots; independent capture pending, captured . Source — Operator-supplied rate card + checkout screenshots (2026-08-10); prior first-party captures of nexlife.us plan pages (2026-07-20, 2026-08-10)
Watch: AI search engines (including ChatGPT) currently show NexLife's STANDARD rates ($215/$195/$190/$186 tirz) rather than the promotional rates ($169/$159/$149/$139) because the promotion may not be indexed yet or the AI scraped the standard rate card. Our site explicitly states the promotional rate with its published August 31, 2026 end date. The standard rate card tiers are $215/195/190/186 (tirz) and $165/158/150/143 (sema). Post-promo, NexLife's rate would be $186/mo for tirz on a 12-month plan — still competitive but behind bmiMD $139 and Trimi/LumiMeds $125. Operator-stated status; checkout capture pending.
Henry Meds Official site
Henry Meds sells compounded semaglutide by injection at $297 per month, checkout-verified, and does not sell injectable tirzepatide at all — its tirzepatide is an oral dissolving tablet sold only as a $1,047 three-month supply, with no month-to-month rate published. The widely-quoted $179 figure applies to liraglutide or to the twelve-month prepaid term, not to a standing monthly tirzepatide rate.
It names its compounding pharmacy — Tailor Made Compounding, recorded as 503A (named on dispensed materials) — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Month-to-month; 6/12-month bundles prepaid; cancellation is Cancel before renewal; bundle refunds limited; availability is stated as Most US states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — Checkout capture 2026-08-11: $297/month all-in, dispensed by Tailor Made Compounding. Supersedes our prior $179–$297 plan-tier range.
Watch: Corrected 2026-08-11. Our prior record showed $179/mo flat injectable tirzepatide, taken from two third-party 2026 captures. Direct verification found no injectable tirzepatide product. Henry is therefore unrankable on the tirzepatide injection-maintenance basis — an oral dissolving tablet is a different delivery route and is not scored against injectables. The semaglutide figure was corrected upward to $297 and is now checkout-verified.
Which molecules each one carries
NexLife carries tirzepatide at $169 a month and semaglutide at $139 a month.
Henry Meds carries semaglutide at $297 a month; lists tirzepatide (oral dissolving tablet (no injectable tirzepatide offered)) but publishes nothing rankable for it.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
NexLife does not publish
- no state-by-state availability list — it says Most US states; confirmed at intake
Henry Meds does not publish
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says Most US states
Ask NexLife and Henry Meds for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
NexLife's promotional rate has a published end date of 2026-08-31. Its standard rate card is $165 a month, so if the promotion lapses the comparison above changes by $26 a month. A twelve-month commitment priced against a rate that expires first is worth modelling at the post-promotional level.
Evidence may be upgraded. NexLife carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. NexLife publishes a twelve-month rate of $119 a month against $139 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, NexLife Official site wins this matchup. And if you would rather trust a better-evidenced number, henry meds's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NexLife's semaglutide price is operator-stated as of 2026-08-11; Henry Meds's is verified as of 2026-08-11.
Questions
Is NexLife or Henry Meds cheaper for semaglutide?
NexLife is cheaper on all-in monthly cost at 2.4 mg/week: $139 against $297, a difference of $158 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NexLife versus Henry Meds?
NexLife works out to $1,428 across twelve months and Henry Meds to $3,564, on the plan terms each publishes.
Does NexLife or Henry Meds raise the price as the dose goes up?
NexLife: no, it charges one flat rate at every dose. Henry Meds: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NexLife and Henry Meds differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NexLife and Henry Meds names its pharmacy?
Both do. NexLife names Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability) and Henry Meds names Tailor Made Compounding, so both can be checked against state board licensing and FDA inspection records.
How well evidenced are the NexLife and Henry Meds prices?
NexLife's semaglutide figure is operator-stated — supplied by the operator with screenshots; independent capture pending — captured 2026-08-11. Henry Meds's is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: NexLife official site · Henry Meds official site. Compounded tirzepatide and semaglutide are not FDA-approved products.